by Brian Shilhavy
Editor, Health Impact News

Senate Majority Leader John Thune, in an interview earlier this week by CNN, when questioned about Robert F. Kennedy’s chances to be confirmed as Trump’s new Secretary of Health and Human Services (HSS), replied:

“He’ll have that opportunity in front of the world this week.”

And so he did, today, January 29, 2024.

I knew that this was one confirmation hearing that I would have to listen to myself, rather than read the spin on this Senate hearing from either the Left Corporate Media, or the Right “Alternative” Media.

So I am presenting the third alternative report here today, from a truly independent source where I have no alliances or allegiances to either side of the political spectrum, and am only interested in reporting the facts, and the truth.

And while I am sure that all other news coverage on this hearing you may have already heard or read about will be on the “hot topics” of political interest to both sides of the political spectrum, the biggest takeaway from my watching the entire Senate hearing, is that the future of medical care in this country is mostly a bipartisan issue that almost everyone on both sides of the political D.C. swamp agree upon: Future innovation and the move to AI and tele-medicine, along with new, novel drugs.

In other words, Big Pharma is still in firm control of the D.C. political swamp, and the only question that still needs to be answered during Trump 2.0 is, who are the ones that are going to make the most money from Big Pharma?

As with probably every other Trump appointee so far, RFK Jr. pledged his allegiance to Donald Trump today, and his first term Operation Warp Speed military operation, calling it “an extraordinary accomplishment and demonstration of leadership by President Trump,” and he promised Senator Thom Tillis that he would not interfere with any future such operations.